Home » Topics » Articles » Insight

Insight
RSS

Other Financings Of Public Biotechnology Companies: October 1998

Nov. 9, 1998

Venture Capital, PIPE/Reg. S And Corporate Investments In Biotechnology Companies: October 1998

Nov. 9, 1998

Biotech Companies Enter Public Markets Through Back Door

Nov. 9, 1998

Money Raised By Biotech In 1998: January October

Nov. 9, 1998

Public Financing Of Biotechnology: October 1998

Nov. 9, 1998

Collaborations Between Biotechnology Companies And Universities, Government Agencies And Nonprofit Institutions: June October 1998

Nov. 2, 1998

Biotechnology Firms Hone Pharmacogenomics Platforms Through Research Ties

Nov. 2, 1998

Agribusiness Drives Agbiotech's Second Wave

Oct. 26, 1998

Agbiotech 1998: New Consortia, Joint Ventures And Research Institutes

Oct. 26, 1998

Biotech-Big Ag Collaborations: January 1998-October 1998

Oct. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...